ARE

Independent Lab Tests Prove CASPR Technology Beats Competitors

Retrieved on: 
Tuesday, March 29, 2022

DALLAS, March 29, 2022 (GLOBE NEWSWIRE) -- Environmental health technology company CASPR Technologies has beat two competing technologies in independent laboratory testing.

Key Points: 
  • DALLAS, March 29, 2022 (GLOBE NEWSWIRE) -- Environmental health technology company CASPR Technologies has beat two competing technologies in independent laboratory testing.
  • Kansas-based Aerosol Research and Engineering (ARE) Laboratories tested CASPR technology against air and surface purification units from two other companies and found that CASPR Tech's models topped out at a 99% reduction in pathogens compared to its competitors' 45% reduction.
  • The two CASPR Tech models used were CASPR PRO 2500 and CASPR MEDIK 14".
  • The value proposition of the NCC technology continues to prove that it is the best path forward when talking about reducing pathogens on surfaces and in the air," said CASPR Technologies co-founder Dr. Christophe Suchy, who invented the technology.

Woodgrain Inc. Announces Commencement of the Tender Offer for All Outstanding Shares of Huttig Building Products, Inc.

Retrieved on: 
Tuesday, March 29, 2022

The tender offer is being made pursuant to the merger agreement (the Merger Agreement) executed on March 20, 2022 and announced by Woodgrain and Huttig on March 21, 2022.

Key Points: 
  • The tender offer is being made pursuant to the merger agreement (the Merger Agreement) executed on March 20, 2022 and announced by Woodgrain and Huttig on March 21, 2022.
  • Additionally, Huttig is filing a solicitation/recommendation statement on Schedule 14D-9 that will include the recommendation of Huttigs board of directors that Huttigs stockholders tender their shares in the tender offer.
  • The tender offer for the outstanding shares of common stock of Huttig has commenced.
  • Woodgrain has filed a tender offer statement on Schedule TO with the SEC, and Huttig will file a solicitation/recommendation statement on Schedule 14D-9 with respect to the offer.

ProKidney Appoints Todd C. Girolamo as General Counsel

Retrieved on: 
Monday, March 28, 2022

WINSTON-SALEM, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on therapies for chronic kidney disease (CKD) and prevention of end-stage renal disease (ESRD) and need for dialysis, today announced the appointment of Todd C. Girolamo as General Counsel.

Key Points: 
  • WINSTON-SALEM, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on therapies for chronic kidney disease (CKD) and prevention of end-stage renal disease (ESRD) and need for dialysis, today announced the appointment of Todd C. Girolamo as General Counsel.
  • We are thrilled to welcome Todd to the ProKidney team in such an important role, said Tim Bertram, Ph.D., Chief Executive Officer of ProKidney.
  • Prior to Caladrius, Girolamo was a biotechnology portfolio manager and analyst at Lions Path Capital, a New York-based investment management company.
  • Neither ProKidney nor SCS gives any assurance that either ProKidney or SCS, or the combined company, will achieve its expectations.

Faraday Future Stock - FFIE Investors Who Have Held Their Securities Since January 2021 May Have Legal Claims - Kehoe Law Firm, P.C.

Retrieved on: 
Wednesday, March 23, 2022

is investigating breach of fiduciary duty claims on behalf of investors of Faraday Future Intelligent Electric Inc. (Faraday Future or the Company) (NASDAQ: FFIE).

Key Points: 
  • is investigating breach of fiduciary duty claims on behalf of investors of Faraday Future Intelligent Electric Inc. (Faraday Future or the Company) (NASDAQ: FFIE).
  • FARADAY FUTURE INVESTORS WHO HAVE HELD THEIR STOCK SINCE JANUARY 2021 ARE ENCOURAGED TO CLICK HERE TO PROVIDE DETAILS ABOUT THEIR FFIE SECURITIES.
  • HOLDERS OF FARADAY FUTURE STOCK SINCE JANUARY 2021 ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT.
  • 804, [email protected] , [email protected] , TO DISCUSS THE FARADAY FUTURE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Murdock Joins NYSIR as Senior VP of Claims

Retrieved on: 
Monday, March 21, 2022

UNIONDALE, N.Y., March 21, 2022 (GLOBE NEWSWIRE) -- The New York Schools Insurance Reciprocal (NYSIR) recently announced that Michael T. Murdock had joined the organization as its senior vice president of claims.

Key Points: 
  • UNIONDALE, N.Y., March 21, 2022 (GLOBE NEWSWIRE) -- The New York Schools Insurance Reciprocal (NYSIR) recently announced that Michael T. Murdock had joined the organization as its senior vice president of claims.
  • He is the author of several books on claims management and has written industry articles on a variety of insurance-related issues.
  • Additionally, he holds various industry designations in insurance, risk management and reinsurance, including CPCU, ARM, ARe, ASLI and ACI.
  • NYSIR is the largest provider of property/casualty insurance for public school districts and BOCES in New York.

AXIS Capital Appoints Fintan Mullarkey as CEO of AXIS Specialty Europe SE

Retrieved on: 
Thursday, March 31, 2022

AXIS Capital Holdings Limited ("AXIS Capital") today announced the appointment of Fintan Mullarkey as CEO of AXIS Specialty Europe SE (ASE), subject to regulatory approval.

Key Points: 
  • AXIS Capital Holdings Limited ("AXIS Capital") today announced the appointment of Fintan Mullarkey as CEO of AXIS Specialty Europe SE (ASE), subject to regulatory approval.
  • ASE is AXIS Capitals Specialty Insurance legal entity domiciled in Ireland and regulated by the Central Bank of Ireland (CBI), with branches in Belgium and the U.K.
  • In this role, Mr. Mullarkey will be responsible for ASE and the legal entity aspects of its branches.
  • Mr. Mullarkey has served as Head of Finance for ASE and AXIS Re SE (ARe) for the past 10 years.

Holborn Corporation Announces Next Generation of Leadership

Retrieved on: 
Tuesday, March 22, 2022

NEW YORK, March 22, 2022 /PRNewswire/ -- Holborn Corporation (Holborn), a U.S.-based independent reinsurance broker, announced a number of Executive promotions within the ranks of its senior Brokers and Analytical Services unit.

Key Points: 
  • NEW YORK, March 22, 2022 /PRNewswire/ -- Holborn Corporation (Holborn), a U.S.-based independent reinsurance broker, announced a number of Executive promotions within the ranks of its senior Brokers and Analytical Services unit.
  • The establishment of our next generational leadership further cements the foundation for driving Holborn forward, as we set our course for the next 100 years."
  • The Executives recently promoted by Holborn are:
    Greg joined Holborn in 2010 as a reinsurance broker with a decade of industry experience at several reinsurance intermediaries.
  • Holborn Corporation (Holborn) is a privately held independent reinsurance brokerage firm established in 1920.

Glancy Prongay & Murray LLP Announce Class Action Settlement Involving Purchasers of Ra Medical Common Stock

Retrieved on: 
Monday, March 21, 2022

YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action have reached a proposed settlement of the Action for $10,000,000 in cash (the "Settlement"), that, if approved, will resolve all claims in the Action.

Key Points: 
  • YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action have reached a proposed settlement of the Action for $10,000,000 in cash (the "Settlement"), that, if approved, will resolve all claims in the Action.
  • If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement Fund.
  • Please do not contact the Court, the Clerk's office, Ra Medical, or its counsel regarding this notice.
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator.

WisdomTree Confirms Receipt of Director Nominations From ETFS Capital Limited and Lion Point Capital

Retrieved on: 
Friday, March 18, 2022

WisdomTree stockholders are not required to take any action at this time.

Key Points: 
  • WisdomTree stockholders are not required to take any action at this time.
  • BofA Securities is serving as financial advisor, and Goodwin Procter LLP is serving as legal counsel to WisdomTree.
  • WisdomTree Investments, Inc., through its subsidiaries in the U.S. and Europe (collectively, WisdomTree), is an ETF and ETP sponsor and asset manager headquartered in New York.
  • WisdomTree is the marketing name for WisdomTree Investments, Inc. and its subsidiaries worldwide.

Volt Information Sciences to be Acquired by an Affiliate of ACS Solutions

Retrieved on: 
Monday, March 14, 2022

Volt’s President and Chief Executive Officer, Linda Perneau, added, “This acquisition offers Volt a compelling opportunity for continued growth. With ACS Solutions as our sister company, we will be in a position to accelerate investments in technology, enhance our capabilities, expand our operations, and ultimately deliver better value to our clients -- all complementing the superior client service that has come to be synonymous with the Volt brand.”

Key Points: 
  • Volt Information Sciences, Inc. (Volt or the Company) (NYSE-AMERICAN: VOLT), a global provider of staffing services, and Vega Consulting, Inc. (Vega), an affiliate of ACS Solutions (ACS Solutions), a global provider of information technology solutions and services ( www.acsicorp.com ), announced today that Volt and Vega have entered into a definitive merger agreement under which Volt will be acquired for $6.00 per share in cash.
  • Volts President and Chief Executive Officer, Linda Perneau, added, This acquisition offers Volt a compelling opportunity for continued growth.
  • ACS Solutions solves complex business challenges with innovative technology solutions that are driven by technical skill, business acumen and passion.
  • ACS Solutions is a global provider of information technology solutions and services with in excess of $1.5 billion in annual revenue.